Maxi-Kalz

Calcium carbonate, the active ingredient in Maxi-Kalz, is a calcium supplement presented as an oral dosage form for oral use. It helps increase elemental calcium intake to support bone mineralization and maintain calcium homeostasis in adults and children with increased needs.

GNH USA supplies Maxi-Kalz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution for healthcare providers. All batches are manufactured under GMP conditions and undergo rigorous testing before release.

Maxi‑Kalz provides calcium supplementation and is used to address conditions where calcium intake is insufficient or bone mineral loss is a concern.

- Osteopenia: helps maintain bone mineral density and reduce risk of progression to osteoporosis. - Osteoporosis (postmenopausal): contributes to bone health maintenance as part of a comprehensive calcium regimen. - Dietary calcium deficiency: restores calcium balance when dietary intake is inadequate. - Pregnancy (when advised): supports fetal skeletal development by supplying needed calcium. - Chronic kidney disease (with medical supervision): provides calcium as part of mineral management to prevent hypocalcemia.

Calcium carbonate is generally well tolerated, but some users may experience adverse reactions.

Common Side Effects: - Constipation: mild to moderate difficulty passing stools. - Flatulence: increased intestinal gas production. - Belching: frequent eructation after ingestion. - Nausea: feeling of queasiness or stomach upset. - Abdominal discomfort: mild pain or cramping in the stomach area.

Serious or Rare Side Effects: - Hypercalcemia: elevated blood calcium levels that may cause weakness, confusion, or cardiac arrhythmia. - Kidney stones: formation of calcium oxalate calculi leading to flank pain and hematuria. - Allergic reaction: rash, itching, swelling, or rare anaphylaxis requiring immediate medical attention. - Severe constipation: prolonged blockage that may need medical intervention.

Before using Maxi‑Kalz, consider the following precautions to ensure safe and effective use.

- Assess total calcium intake: avoid exceeding recommended daily amounts to prevent excess calcium accumulation. - Monitor serum calcium levels: especially in patients with renal impairment or disorders of calcium metabolism. - Review concomitant medications: calcium may interfere with absorption of iron, bisphosphonates, and certain antibiotics. - Use cautiously in hyperparathyroidism: excess calcium can exacerbate calcium imbalance. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Calcium carbonate can affect the absorption or action of several medicines; appropriate management is recommended.

Major Interactions (Avoid): - Iron supplements: calcium reduces iron absorption, decreasing its efficacy. - Bisphosphonates: calcium chelates the drug, impairing its anti‑resorptive effect. - Tetracycline antibiotics: calcium forms insoluble complexes, limiting antibiotic availability.

Moderate Interactions (Monitor Closely): - Thyroid hormone replacement: calcium may decrease levothyroxine absorption; separate dosing times. - Proton pump inhibitors: altered gastric pH can affect calcium carbonate dissolution and absorption. - Loop diuretics: increased calcium excretion may require monitoring of calcium status.